Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy.
Linders D, Deken M, van der Valk M, Tummers W, Bhairosingh S, Schaap D, van Lijnschoten G, Zonoobi E, Kuppen P, van de Velde C, Vahrmeijer A, Farina Sarasqueta A, Sier C, Hilling D. Linders D, et al. Among authors: van lijnschoten g. Diagnostics (Basel). 2021 Mar 14;11(3):516. doi: 10.3390/diagnostics11030516. Diagnostics (Basel). 2021. PMID: 33799475 Free PMC article.
PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis.
Fariña Sarasqueta A, Zeestraten EC, van Wezel T, van Lijnschoten G, van Eijk R, Dekker JW, Kuppen PJ, Goossens-Beumer IJ, Lemmens VE, van de Velde CJ, Rutten HJ, Morreau H, van den Brule AJ. Fariña Sarasqueta A, et al. Among authors: van den brule aj, van lijnschoten g, van eijk r, van wezel t, van de velde cj. Cell Oncol (Dordr). 2011 Dec;34(6):523-31. doi: 10.1007/s13402-011-0054-4. Epub 2011 Aug 10. Cell Oncol (Dordr). 2011. PMID: 21830111
Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
Voogt ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, Bloemen JG, Creemers GJ, Willems J, Cnossen JS, Peulen HMU, Nederend J, van Lijnschoten G, Burger JWA, Rutten HJT. Voogt ELK, et al. Among authors: van lijnschoten g. Eur J Surg Oncol. 2021 Sep;47(9):2429-2435. doi: 10.1016/j.ejso.2021.05.017. Epub 2021 May 18. Eur J Surg Oncol. 2021. PMID: 34030921
Reply to: Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
Voogt ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, Bloemen JG, Creemers GJ, Willems J, Cnossen JS, Peulen HMU, Nederend J, van Lijnschoten G, Burger JWA, Rutten HJT. Voogt ELK, et al. Among authors: van lijnschoten g. Eur J Surg Oncol. 2021 Sep;47(9):2473-2474. doi: 10.1016/j.ejso.2021.06.021. Epub 2021 Jun 24. Eur J Surg Oncol. 2021. PMID: 34210580 No abstract available.
Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy.
Nordkamp S, Piqeur F, van den Berg K, Tolenaar JL, van Hellemond IEG, Creemers GJ, Roef M, van Lijnschoten G, Cnossen JS, Nieuwenhuijzen GAP, Bloemen JG, Coolen L, Nederend J, Peulen HMU, Rutten HJT, Burger JWA. Nordkamp S, et al. Among authors: van lijnschoten g. Br J Surg. 2023 Jul 17;110(8):950-957. doi: 10.1093/bjs/znad094. Br J Surg. 2023. PMID: 37243705
43 results